Cargando…
Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
Brain metastases (BMs) are the most common intracranial malignancy with poor prognosis. Patients with intracranial tumors are at greater risk for thrombotic complications and intracranial hemorrhage. Rivaroxaban is a potent oral anticoagulant with the high selectivity of direct factor Xa inhibition....
Autores principales: | Chen, Luyue, Chen, E, Huang, Yanlin, Tian, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035493/ https://www.ncbi.nlm.nih.gov/pubmed/33869783 http://dx.doi.org/10.1515/med-2021-0261 |
Ejemplares similares
-
Intracranial Hemorrhage in Patient Treated with Rivaroxaban
por: Molina, Michelle, et al.
Publicado: (2014) -
Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma
por: Nakagawa, Takashi, et al.
Publicado: (2022) -
Intravesicular Onabotulinumtoxin A Hemorrhage on Rivaroxaban
por: Eubanks, Allison, et al.
Publicado: (2019) -
Premature MicroRNA-Based Therapeutic: A “One-Two Punch” against Cancers
por: Chen, Luyue, et al.
Publicado: (2020) -
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma
por: Shang, Runze, et al.
Publicado: (2021)